CNO Financial Group 3Q 2026: Revenue $1.09B, EPS $1.71 — 10-Q Summary
Moins d'1 minute de lecture
CNO Financial Group’s revenue declined year over year, while net income rose. Higher insurance product margins and investment income not allocated to product lines supported earnings; lower investment results weighed on revenue, while the absence of the prior-year impairment charge also aided the comparison.
Financial Highlights
| Metric | Current quarter | Prior year quarter | YoY change |
| Revenue¹ | $1.09B | $1.19B | (8.6%) |
| Net income² | $161.1M | $23.1M | 597.4% |
| Diluted EPS³ | $1.71 | $0.24 | 612.5% |
¹ Reported as “Total revenues”. ² Reported as “Net income”. ³ Reported as “Net income”.
Business Highlights
- Insurance margins: Total insurance product margin increased to $333.0 million from $300.5 million; annuity and life margins rose, while health margin declined.
- Investment income: Investment income not allocated to product lines rose to $68.1 million from $39.5 million, reflecting higher alternative investment results and increased FHLB and FABN spread income.
- Actuarial review: The annual review had a net favorable $56.3 million impact on pre-tax operating earnings and a net favorable $36.0 million impact on net income.
- 2026 outlook: Full-year operating earnings per diluted share guidance rose to $5.05-$5.15; expected expense ratio narrowed to 18.6%-18.8%.
Original SEC Filing: CNO Financial Group, Inc. [ CNO ] - 10-Q - Nov. 05, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.